 Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors that purchased Chembio Diagnostics, Inc. NASDAQ: CEMI common stock between March 12, 2020 and June 16, 2020 the Class Period. Investors have until August 17, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit. 